Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1997;28:1423-1429

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akiguchi, I.
Right arrow Articles by Budka, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akiguchi, I.
Right arrow Articles by Budka, H.

(Stroke. 1997;28:1423-1429.)
© 1997 American Heart Association, Inc.


Articles

Alterations in Glia and Axons in the Brains of Binswanger's Disease Patients

Ichiro Akiguchi, MD; Hidekazu Tomimoto, MD; Toshihiko Suenaga, MD; Hideaki Wakita, MD; Herbert Budka, MD

From the Department of Neurology, Faculty of Medicine, Kyoto University, Kyoto 606 Japan (I.A., H.T., T.S., H.W.), and the Institute of Neurology, University of Vienna, A-1097 Wien, Austria (H.B.).

Correspondence to I. Akiguchi, MD, Department of Neurology, Faculty of Medicine, Kyoto University, Kyoto 606 Japan.

Background and Purpose Although increasing attention is being paid to Binswanger's disease, a form of vascular dementia characterized by diffuse white matter lesions, only limited information is available on the pathological changes that occur in the glia and axons in the white matter. We therefore investigated the brains of patients with Binswanger's disease to gain further insight into its pathophysiology.

Methods Autopsied brains from patients with Binswanger's disease (group 3; n=17) were compared with those of non-neurological controls (group 1; n=5) and controls with large cortical infarcts but without significant white matter lesions (group 2; n=5). Glial fibrillary acidic protein (GFAP) was used as an immunohistochemical marker for astroglia, leukocyte common antigen (LCA) was used as a marker for microglia, and HLA-DR was used as a marker for activated microglia. Axonal damage was assessed by the accumulation of proteins, which are transported by fast axonal flow, amyloid protein precursor (APP), synaptophysin, and chromogranin A.

Results Although there was no difference in numerical density of GFAP-immunoreactive astroglia in each group, regressive astroglia were observed in 7 of 17 patients with Binswanger's disease. LCA-immunoreactive microglia were 1.7 times more numerous in Binswanger's disease than in group 1 (P<.05). HLA-DR–immunoreactive–activated microglia were 3.4 times and 2.1 times more numerous in Binswanger's disease as compared with group 1 (P<.01) and group 2 (P<.05), respectively. There was frequent perivascular lymphocyte cuffing, and clusters of macrophages with a decreased number of oligodendroglia were observed in the rarefied white matter. The grading scores for the number of axons immunoreactive for either APP, synaptophysin, or chromogranin A were significantly higher in Binswanger's disease than in group 1 or 2.

Conclusions The pathological alterations in Binswanger's diseased brains include regressive changes in the astroglia and activation of the microglia with a decrease in the oligodendroglia, which were associated with the degradation of both myelin and axonal components. These results indicate that an inflammatory reaction and compromised axonal transport, mediated by chronic ischemia, may play an important role in the pathophysiology of Binswanger's disease.


Key Words: white matter • Binswanger's disease • astrocytes • microglia




This article has been cited by other articles:


Home page
StrokeHome page
H. Ay, E. M. Arsava, J. Rosand, K. L. Furie, A. B. Singhal, P. W. Schaefer, O. Wu, R. G. Gonzalez, W. J. Koroshetz, and A. G. Sorensen
Severity of Leukoaraiosis and Susceptibility to Infarct Growth in Acute Stroke
Stroke, May 1, 2008; 39(5): 1409 - 1413.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. J. van Dijk, N. D. Prins, S. E. Vermeer, H. A. Vrooman, A. Hofman, P. J. Koudstaal, and M. M.B. Breteler
C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study
Circulation, August 9, 2005; 112(6): 900 - 905.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Agren-Wilsson, A Eklund, L-O D Koskinen, A T Bergenheim, and J Malm
Brain energy metabolism and intracranial pressure in idiopathic adult hydrocephalus syndrome
J. Neurol. Neurosurg. Psychiatry, August 1, 2005; 76(8): 1088 - 1093.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Ihara, H. Tomimoto, K. Ishizu, T. Mukai, H. Yoshida, N. Sawamoto, M. Inoue, T. Doi, K. Hashikawa, J. Konishi, et al.
Decrease in Cortical Benzodiazepine Receptors in Symptomatic Patients With Leukoaraiosis: A Positron Emission Tomography Study
Stroke, April 1, 2004; 35(4): 942 - 947.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
G. T. Lim, M. F. Mendez, Y. L. Bronstein, L. Jouben-Steele, and H. V. Vinters
Clinicopathologic Case Report: Akinetic Mutism With Findings of White Matter Hyperintensity
J Neuropsychiatry Clin Neurosci, May 1, 2002; 14(2): 214 - 221.
[Full Text] [PDF]


Home page
StrokeHome page
J. Helenius, L. Soinne, O. Salonen, M. Kaste, and T. Tatlisumak
Leukoaraiosis, Ischemic Stroke, and Normal White Matter on Diffusion-Weighted MRI
Stroke, January 1, 2002; 33(1): 45 - 50.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
E. Miyamoto, H. Tomimoto, S.-i. Nakao, H. Wakita, I. Akiguchi, K. Miyamoto, and K. Shingu
Caudoputamen Is Damaged by Hypocapnia During Mechanical Ventilation in a Rat Model of Chronic Cerebral Hypoperfusion
Stroke, December 1, 2001; 32(12): 2920 - 2925.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
H. Tomimoto, I. Akiguchi, R. Ohtani, H. Yagi, M. Kanda, H. Shibasaki, and Y. Yamamoto
The Coagulation-Fibrinolysis System in Patients With Leukoaraiosis and Binswanger Disease
Arch Neurol, October 1, 2001; 58(10): 1620 - 1625.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. A. Rosenberg, N. Sullivan, M. M. Esiri, and R. A. Sobel
White Matter Damage Is Associated With Matrix Metalloproteinases in Vascular Dementia Editorial Comment : Matrix Metalloproteinases and Diffuse White Matter Injury
Stroke, May 1, 2001; 32(5): 1162 - 1168.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J.-X. Lin, H. Tomimoto, I. Akiguchi, A. Matsuo, H. Wakita, H. Shibasaki, and H. Budka
Vascular Cell Components of the Medullary Arteries in Binswanger's Disease Brains : A Morphometric and Immunoelectron Microscopic Study
Stroke, August 1, 2000; 31(8): 1838 - 1842.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Tullberg, J-E Mansson, P Fredman, A Lekman, K Blennow, R Ekman, L E Rosengren, M Tisell, and C Wikkelso
CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy
J. Neurol. Neurosurg. Psychiatry, July 1, 2000; 69(1): 74 - 81.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
H. Tomimoto, I. Akiguchi, H. Wakita, A. Osaki, M. Hayashi, and Y. Yamamoto
Coagulation Activation in Patients With Binswanger Disease
Arch Neurol, September 1, 1999; 56(9): 1104 - 1108.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Okada, L.-H. Wu, and S. Kobayashi
Diffusion-Weighted MRI in Severe Leukoaraiosis
Stroke, February 1, 1999; 30(2): 478 - 479.
[Full Text] [PDF]


Home page
NeurologyHome page
I. Akiguchi, H. Tomimoto, M. Kinoshita, H. Wakita, A. Osaki, M. Nishimura, and J. Kimura
Effects of antithrombin on Binswanger's disease with antiphospholipid antibody syndrome
Neurology, January 1, 1999; 52(2): 398 - 398.
[Abstract] [Full Text]